News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

No Significant Differences In BioGaia’s Diabetes Study



1/28/2014 8:55:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

In 2012 BioGaia initiated a double-blind, placebo-controlled study to investigate the effects of Lactobacillus reuteri Protectis on blood glucose in type 2 diabetics. Despite positive results from an earlier pilot study no significant differences between the groups were seen in this study. Forty-five patients with type 2 diabetes were included in the 12-week long study. The analysis of the results will continue to capitalise on as much knowledge as possible.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES